Imunon shareholders approve increase in authorized shares to 350M and reverse split up to 1:18

Imunon, Inc.

Authorized common shares increased from 112.5M to 350M; amendment effective July 11, 2025.
Reverse stock split approved at board's discretion with ratio between 1:5 and 1:18; no effective date set.
Approved issuance of shares underlying warrants from May 2025 securities purchase agreement with investors.
Amendment to 2018 Stock Incentive Plan approved; shares available for issuance increased.
Directors elected: Michael H. Tardugno and Dr. Donald P. Braun as Class III directors until 2028 annual meeting.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Imunon, Inc.: Approved amendment to Restated Certificate of Incorporation to increase authorized common shares from 112,500,000 to 350,000,000 and make corresponding change to authorized capital stock (effective 2025-07-11).

Change: charter amendment
Effective: 2025-07-11

Exact text from the filing

the Company’s stockholders voted on and approved an amendment (the “Amendment”) to the Company’s Restated Certificate of Incorporation (the “Certificate of Incorporation”), to increase the number of authorized shares of common stock from 112,500,000 shares to 350,000,000 shares, and to make a corresponding change to the number of authorized shares of capital stock

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Imunon, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-018797

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.